Rx Only DESCRIPTION hydrochloride ( Propranolol is a synthetic beta - adrenergic receptor blocking agent chemically described as 2 - Propanol , 1 - [ ( 1 - methylethyl ) amino ] - 3 - ( 1 - naphthalenyloxy ) - , hydrochloride , ( ± ) - .
It ’ s molecular and structural formulae are : [ MULTIMEDIA ] Propranolol hydrochloride is a stable , white , crystalline solid which is readily soluble in water and in ethanol .
Its molecular weight is 295 . 80 .
Propranolol hydrochloride tablets , USP are available as 10 mg , 20 mg , 40 mg , 60 mg , and 80 mg tablets for oral administration .
The inactive ingredients contained in propranolol hydrochloride tablets , USP are : lactose monohydrate , corn starch , sodium starch glycolate , magnesium stearate , and povidone .
In addition , propranolol hydrochloride tablets , USP 10 mg , 40 mg and 80 mg contain and C yellow No . 6 Aluminium Lake and Color D and C Yellow No . 10 ; propranolol hydrochloride tablets , USP 20 mg and 40 mg contain FD and C Blue No . 1 and propranolol hydrochloride tablets , USP 60 mg contain D and C Red No . 30 Lake .
[ MULTIMEDIA ] CONTRAINDICATIONS Propranolol is contraindicated in 1 ) cardiogenic shock ; 2 ) sinus bradycardia and greater than first degree block ; 3 ) bronchial asthma ; and 4 ) in patients with known hypersensitivity to propranolol hydrochloride .
ADVERSE REACTIONS The following adverse events were observed and have been reported in patients using propranolol .
Cardiovascular : Bradycardia ; congestive heart failure ; intensification of AV block ; hypotension ; paresthesia of hands ; thrombocytopenic purpura ; arterial insufficiency , usually of the Raynaud type .
Central Nervous System : Lightheadedness , mental depression manifested by insomnia , lassitude , weakness , fatigue ; catatonia ; visual disturbances ; hallucinations ; vivid dreams ; an acute reversible syndrome characterized by disorientation for time and place , short - term memory loss , emotional lability , slightly clouded sensorium , and decreased performance on neuropsychometrics .
For immediate - release formulations , fatigue , lethargy , and vivid dreams appear dose - related .
Gastrointestinal : Nausea , vomiting , epigastric distress , abdominal cramping , diarrhea , constipation , mesenteric arterial thrombosis , ischemic colitis .
Allergic : Hypersensitivity reactions , including anaphylactic / anaphylactoid reactions , pharyngitis and agranulocytosis ; erythematous rash , fever combined with aching and sore throat ; laryngospasm , and respiratory distress .
Respiratory : Bronchospasm .
Hematologic : Agranulocytosis , nonthrombocytopenic purpura , thrombocytopenic purpura .
Autoimmune : Systemic lupus erythematosus ( SLE ) .
Skin and mucous membranes : Stevens - Johnson Syndrome , toxic epidermal necrolysis , dry eyes , exfoliative dermatitis , erythema multiforme , urticaria , alopecia , SLE - like reactions , and psoriasiform rashes .
Oculomucocutaneous syndrome involving the skin , serous membranes and conjunctivae reported for a beta - blocker ( practolol ) have not been associated with propranolol .
Genitourinary : Male impotence ; Peyronie ’ s disease .
OVERDOSAGE Propranolol is not significantly dialyzable .
In the event of overdosage or exaggerated response , the following measures should be employed : General : If ingestion is or may have been recent , evacuate gastric contents , taking care to prevent pulmonary aspiration .
Supportive Therapy : Hypotension and bradycardia have been reported following propranolol overdose and should be treated appropriately .
Glucagon can exert potent inotropic and chronotropic effects and may be particularly useful for the treatment of hypotension or depressed myocardial function after a propranolol overdose .
Glucagon should be administered as 50 - 150 mcg / kg intravenously followed by continuous drip of 1 - 5 mg / hour for positive chronotropic effect .
Isoproterenol , dopamine or phosphodiesterase inhibitors may also be useful .
Epinephrine , however , may provoke uncontrolled hypertension .
Bradycardia can be treated with atropine or isoproterenol .
Serious bradycardia may require temporary cardiac pacing .
The electrocardiogram , pulse , blood pressure , neurobehavioral status and intake and output balance must be monitored .
Isoproterenol and aminophylline may be used for bronchospasm .
HOW SUPPLIED Propranolol hydrochloride tablets , USP are supplied as follows : 10 mg : Each tablet is an orange colored , round , biconvex tablet , embossed with " P " and " 10 " on either side of the breakline on one side and plain on the other side .
Each 10 mg tablet contains 10 mg propranolol hydrochloride USP and is supplied in the following packages sizes : Bottles of 30 tablets NDC 23155 - 110 - 03 Bottles of 60 tablets NDC 23155 - 110 - 06 Bottles of 100 tablets NDC 23155 - 110 - 01 Bottles of 500 tablets NDC 23155 - 110 - 05 Bottles of 1000 tablets NDC 23155 - 110 - 10 20 mg : Each tablet is a blue colored , round , biconvex tablet , embossed with " P " and " 20 " on either side of the breakline on one side and plain on the other side .
Each 20 mg tablet contains 20 mg of propranolol hydrochloride USP and is supplied in the following package sizes : Bottles of 30 tablets NDC 23155 - 111 - 03 Bottles of 60 tablets NDC 23155 - 111 - 06 Bottles of 100 tablets NDC 23155 - 111 - 01 Bottles of 500 tablets NDC 23155 - 111 - 05 Bottles of 1000 tablets NDC 23155 - 111 - 10 40 mg : Each tablet is a green colored , round , biconvex tablet , embossed with " P " and " 40 " on either side of the breakline on one side and plain on the other side .
Each 40 mg tablet contains 40 mg of propranolol hydrochloride USP and is supplied in the following package sizes : Bottles of 30 tablets NDC 23155 - 112 - 03 Bottles of 60 tablets NDC 23155 - 112 - 06 Bottles of 100 tablets NDC 23155 - 112 - 01 Bottles of 500 tablets NDC 23155 - 112 - 05 Bottles of 1000 tablets NDC 23155 - 112 - 10 60 mg : Each tablet is a pink colored , round , biconvex tablet , embossed with " P " and " 60 " on either side of the breakline on one side and plain on the other side .
Each 60 mg tablet contains 60 mg of propranolol hydrochloride USP and is supplied in the following package sizes : Bottles of 30 tablets NDC 23155 - 113 - 03 Bottles of 60 tablets NDC 23155 - 113 - 06 Bottles of 100 tablets NDC 23155 - 113 - 01 Bottles of 500 tablets NDC 23155 - 113 - 05 Bottles of 1000 tablets NDC 23155 - 113 - 10 80 mg : Each tablet is a yellow colored , round , biconvex tablet , embossed with " P " and " 80 " on either side of the breakline on one side and plain on the other side .
Each 80 mg tablet contains 80 mg of propranolol hydrochloride USP and is supplied in the following package sizes : Bottles of 30 tablets NDC 23155 - 114 - 03 Bottles of 60 tablets NDC 23155 - 114 - 06 Bottles of 100 tablets NDC 23155 - 114 - 01 Bottles of 500 tablets NDC 23155 - 114 - 05 Bottles of 1000 tablets NDC 23155 - 114 - 10 Storage : Store at 20 ° - 25 ° C ( 68 - ( ° 77 ( ° F ) ; excursions permitted to 15 ° - 30 ( ° C ( 59 ( ° - 86 ( ° F ) [ see USP Controlled Room Temperature ] Protect from light .
Dispense in a well closed , light - resistant container as defined in USP .
Call your doctor for medical advice about side effects .
You may report side effects to FDA at 1 - 800 - FDA - 1088 .
Manufactured for : Heritage Pharmaceuticals Inc .
Edison , NJ 08837 1 . 866 . 901 .
DRUG ( 3784 ) Manufactured by : Ipca Laboratories Limited 48 , Kandivli Ind .
Estate , Mumbai 400 067 , India .
[ MULTIMEDIA ] Iss .
0109 [ MULTIMEDIA ] PRINCIPAL DISPLAY PANEL [ MULTIMEDIA ] NDC 68258 - 6010 - XX NDC 68258 - 6010 - 03 NDC 68258 - 6010 - 09 [ MULTIMEDIA ]
